Here's the skinny on the weight loss drugs that disappointed, the hepatitis drugs that matched the hype and others as we look back on the major headlines relating to medications in 2010.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Road rules for drugs: a survey of signals. Nat Med 16, 1362–1363 (2010). https://doi.org/10.1038/nm1210-1362
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1210-1362
